Liver Cancer Trial, Recruiting NCT05866783 Sponsor: University Hospital, Ghent Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT05866783
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have signed and dated a consent form agreeing to take part in the study
  • You have been diagnosed with hepatocellular carcinoma (a type of liver cancer)
  • You are 18 years of age or older
  • You are able to attend scheduled appointments and follow the study requirements
  • You are considered eligible for a liver transplant and/or are already on the waiting list for a liver transplant
  • You have had a consultation with a Gastroenterology and Hepatology department (a team of doctors who specialise in liver conditions)

Who may not be able to join:

  • You have been diagnosed with a different type of liver tumour, such as cancer that has spread to the liver from another part of the body, or a cancer of the bile ducts (confirm with trial site if you are unsure which category applies to you)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 9 332 23 71

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Ghent
Registry
ClinicalTrials.gov
Start date
28 April 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

HCC recurrence; Disease-free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov